Unicycive Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.03 Insider Own0.20% Shs Outstand15.06M Perf Week4.46%
Market Cap10.49M Forward P/E- EPS next Y-0.96 Insider Trans0.00% Shs Float8.91M Perf Month1.27%
Income-15.50M PEG- EPS next Q-0.20 Inst Own18.30% Short Float / Ratio0.61% / 1.94 Perf Quarter4.31%
Sales1.00M P/S10.49 EPS this Y-327.70% Inst Trans-7.02% Short Interest0.05M Perf Half Y-16.67%
Book/sh0.31 P/B2.26 EPS next Y8.60% ROA-107.70% Target Price9.62 Perf Year-65.00%
Cash/sh0.47 P/C1.50 EPS next 5Y- ROE-139.90% 52W Range0.51 - 2.35 Perf YTD-66.02%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-70.21% Beta-
Dividend %- Quick Ratio1.80 Sales past 5Y- Gross Margin- 52W Low36.96% ATR0.08
Employees9 Current Ratio1.80 Sales Q/Q- Oper. Margin- RSI (14)50.19 Volatility8.80% 15.08%
OptionableNo Debt/Eq0.00 EPS Q/Q-0.50% Profit Margin- Rel Volume0.12 Prev Close0.73
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume28.03K Price0.70
Recom2.00 SMA20-1.51% SMA505.75% SMA200-20.33% Volume3,390 Change-3.47%
Nov-28-22 07:00AM
Nov-21-22 10:32AM
Nov-14-22 07:00AM
Nov-10-22 07:00AM
09:00AM Loading…
Nov-08-22 09:00AM
Oct-26-22 08:04AM
Oct-12-22 08:00AM
Sep-29-22 07:00AM
Sep-23-22 09:11AM
Sep-07-22 07:00AM
Sep-06-22 07:00AM
Aug-24-22 07:00AM
Aug-15-22 06:03PM
Jul-26-22 07:00AM
07:12AM Loading…
Jul-20-22 07:12AM
Jul-18-22 07:48AM
Jun-29-22 12:00PM
Jun-06-22 08:00AM
Jun-02-22 08:00AM
May-24-22 08:00AM
May-12-22 07:00AM
Apr-14-22 07:10AM
Mar-31-22 07:00AM
Mar-23-22 08:30AM
Mar-03-22 07:00AM
Feb-02-22 07:00AM
Jan-10-22 07:00AM
Nov-29-21 07:00AM
09:14AM Loading…
Nov-11-21 09:14AM
Oct-26-21 07:30AM
Sep-15-21 06:17AM
Sep-07-21 06:00AM
Aug-16-21 06:00AM
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schiller BrigitteDirectorJul 15Option Exercise0.0026,738026,738Aug 30 05:01 PM
Schiller BrigitteDirectorMay 16Buy0.8215,00012,37515,000May 17 11:04 AM